Institute for Systems Biology focuses on some of the most pressing issues in human health, including cancer and brain health. ISB President and Professor James Heath, PhD, is a PICI investigator who bridges cutting-edge technology and immune system biology. He builds new technologies to investigate how individual patients’ immune systems respond to therapeutic interventions including vaccines, checkpoint blockade and CAR-T cell therapy. He collaborates with PICI in high-need areas, pushing progress in glioblastoma and brain tumor research. James Heath, PhD | Investigator Related Research Focus Tumor Antigen Discovery: Targeting Cancer Research Project Tumor Neoantigen Selection Alliance (TESLA) Cancer Research Heroes The Power of Patient Samples Research Project REVIVE Announcement, Press Release The Parker Institute for Cancer Immunotherapy Appoints Seasoned Health Care Leader Frederic Pla as Chief Operating Officer Research Update A Collaborative Effort Aims to Change the Future of Patient Care With Cancer Immunotherapy Point of View An Immunologist Breaks Down COVID-19 Announcement A message from PICI: Thank you to those addressing this global pandemic Announcement 2019 Annual Report
Announcement, Press Release The Parker Institute for Cancer Immunotherapy Appoints Seasoned Health Care Leader Frederic Pla as Chief Operating Officer
Research Update A Collaborative Effort Aims to Change the Future of Patient Care With Cancer Immunotherapy